NEW DELHI - A lawyer for healthcare activists says India's Supreme Court has rejected drug maker Novartis AG's right to patent a new version of a lifesaving cancer drug.
The landmark ruling Monday is a victory for India's $26 billion generic drug industry that provides cheap medicines to millions around the world.
The ruling is a precedent that prevents international pharmaceutical companies from obtaining fresh patents in India on updated versions of existing drugs.
Lawyer Anand Grover said such a ruling would help poor people get access to affordable, generic versions of lifesaving medicines.
Novartis has fought a legal battle in India since 2006 for a fresh patent for a leukemia drug.
India's patent office had rejected the company's patent application because it was not a new medicine.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Inside the Baltimore Police Department's watch center is the hub from which city police can view hundreds of crime cameras, pull up street corners and follow suspicious activity sometimes in progress; fancy hardware increasingly complimenting witty software.
ABC2 Investigators uncover Baltimore Police officers making huge amounts of overtime as the agency downplays the total amount spent on OT.
Scripps reviewed dozens of lawsuits and spoke with former insiders who all allege the companies that handle Berkshire Hathaway Inc.’s asbestos and pollution claims, wrongfully delay or deny payment to cancer victims...
A 79-year-old is in critical condition after being hit by a car near Cradlerock Way and Dockside Lane in Columbia.